JP2022543046A5 - - Google Patents

Info

Publication number
JP2022543046A5
JP2022543046A5 JP2022506419A JP2022506419A JP2022543046A5 JP 2022543046 A5 JP2022543046 A5 JP 2022543046A5 JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022543046 A5 JP2022543046 A5 JP 2022543046A5
Authority
JP
Japan
Prior art keywords
drawings
present specification
invention described
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543046A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044196 external-priority patent/WO2021022008A1/en
Publication of JP2022543046A publication Critical patent/JP2022543046A/ja
Publication of JP2022543046A5 publication Critical patent/JP2022543046A5/ja
Pending legal-status Critical Current

Links

JP2022506419A 2019-07-30 2020-07-30 ウイルス様粒子ワクチン Pending JP2022543046A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962880547P 2019-07-30 2019-07-30
US62/880,547 2019-07-30
US202062990318P 2020-03-16 2020-03-16
US62/990,318 2020-03-16
PCT/US2020/044196 WO2021022008A1 (en) 2019-07-30 2020-07-30 Virus-like particle vaccines

Publications (2)

Publication Number Publication Date
JP2022543046A JP2022543046A (ja) 2022-10-07
JP2022543046A5 true JP2022543046A5 (https=) 2023-08-07

Family

ID=74228282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506419A Pending JP2022543046A (ja) 2019-07-30 2020-07-30 ウイルス様粒子ワクチン

Country Status (7)

Country Link
US (2) US20220280633A1 (https=)
EP (1) EP4004036A4 (https=)
JP (1) JP2022543046A (https=)
CN (1) CN114729030A (https=)
AU (1) AU2020321021A1 (https=)
CA (1) CA3149390A1 (https=)
WO (1) WO2021022008A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20240586T1 (hr) 2018-10-09 2024-07-19 The University Of British Columbia Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima
WO2022008973A2 (en) * 2020-07-10 2022-01-13 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN112760420B (zh) * 2021-02-05 2023-05-26 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN114656529B (zh) * 2021-02-08 2024-05-31 暨南大学 一种新型冠状病毒t细胞的抗原表位肽及其应用
US20220265601A1 (en) * 2021-02-10 2022-08-25 David Alan Heldreth, JR. Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses.
CN114957409A (zh) * 2021-02-26 2022-08-30 中国科学院上海巴斯德研究所 基于s蛋白r815位点的冠状病毒干预的方法和产品
CA3211083A1 (en) * 2021-03-04 2022-09-09 Kyle BACKMAN Compositions including sbi adjuvants and methods of use thereof
WO2022191742A1 (en) * 2021-03-11 2022-09-15 Dukhovlinov Ilya Vladimirovich A method for assessment of the cellular immune
CA3218711A1 (en) * 2021-05-13 2022-11-17 Roee Amit Methods and compositions for treatment of viral infection
WO2022261355A1 (en) * 2021-06-09 2022-12-15 Chimeron Bio Corporation Self-amplifying rna-based vlp vaccines
CN115572714A (zh) * 2021-06-21 2023-01-06 江苏泽凯生物医药技术有限公司 一种快速检测SARS-CoV-2病毒中和抗体有效性的方法
US20250082236A1 (en) * 2021-07-19 2025-03-13 Carnegie Mellon University Scalable Manufacturing of Microneedle Arrays Using Automated High-Throughput Manufacturing Systems and High-Capacity Molding
WO2023023597A1 (en) * 2021-08-18 2023-02-23 Nanored Llc Virus-like particle
IL310010A (en) * 2021-09-09 2024-03-01 Universit?T Basel Biologically produced nucleic acid for vaccine production
US20250134986A1 (en) * 2021-09-15 2025-05-01 Verndari, Inc. Stabilized lipid nanoparticle mrna compositions and uses thereof
WO2023062651A1 (en) * 2021-10-13 2023-04-20 Padmanabh Patil Harshad Virus-like particles for respiratory syncytial virus and method of preparation thereof
RU2769224C1 (ru) * 2021-12-30 2022-03-29 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Рекомбинантные вирусоподобные частицы для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2
KR20260032590A (ko) * 2023-06-29 2026-03-09 세퀴러스 인코포레이티드 재조합 바이러스 유사 입자
WO2025235418A1 (en) * 2024-05-05 2025-11-13 National Health Research Institutes Virus-like particle, preparation method thereof, and use thereof in preparing vaccine
WO2025264980A1 (en) * 2024-06-21 2025-12-26 Georgia Tech Research Corporation Ambient stabilization of mrna-hybrid lipid nanocapsules in sugar glass

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) * 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
BR0311995A (pt) * 2002-06-20 2005-04-05 Cytos Biotechnology Ag Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
CA2689042A1 (en) * 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
WO2011002522A2 (en) * 2009-07-02 2011-01-06 Medimmune, Llc Methods of making and using synthetic viruses
JP2013542928A (ja) * 2010-09-30 2013-11-28 フランバックス ソチエタ レスポンサビリタ リミテ ビロソーム粒子の生成
ES2729967T3 (es) * 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
US10829543B2 (en) * 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
WO2016039620A2 (en) * 2014-09-12 2016-03-17 Bestewil Holding B.V. Respiratory syncytial virus virosomes
WO2016039619A1 (en) * 2014-09-12 2016-03-17 Bestewil Holding B.V. Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby
US10676511B2 (en) * 2015-09-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Coronaviruses epitope-based vaccines

Similar Documents

Publication Publication Date Title
JP2023518821A5 (https=)
JP2021184963A5 (https=)
JP2023171775A5 (https=)
JP2023103258A5 (https=)
JP2022184985A5 (https=)
JP2023166402A5 (https=)
JP2022543046A5 (https=)
JP2022538797A5 (https=)
JP2023145572A5 (https=)
JP2022028828A5 (https=)
JP2022025124A5 (https=)
JP2021185136A5 (https=)
JP2022541332A5 (https=)
JP2023514727A5 (https=)
JP2020127428A5 (https=)
JP2021038271A5 (https=)
JP2023552816A5 (https=)
JP2021512414A5 (https=)
JP2023181322A5 (https=)
JPWO2020148954A5 (https=)
JP2024045126A5 (https=)
JP2020171301A5 (https=)
JP2020120660A5 (https=)
JP2022537813A5 (https=)
JP2023093656A5 (https=)